MANE

Veradermics, Inc

A clinical-stage biopharmaceutical company developing VDPHL01, an oral, non-hormonal extended-release form of minoxidil designed to grow hair while limiting heart-related side effects, for men and women with pattern hair loss. It was founded in 2019 by dermatologists who met at MIT's Hacking Dermatology competition, and its name blends the Latin for "true" with the Greek for "skin."